Featured Courses

Optimizing Care for Prurigo Nodularis - Evidence-Based Treatment Approaches and Personalized Strategies

Dermatology

Course Description: Prurigo nodularis (PN) has a significant impact on patient’s quality of life and can be difficult to...

Antibody Drug Conjugates (ADC) - United States

Oncology

Course Description: This module is designed to offer healthcare professionals a thorough understanding of the wide range...

The Impact of Non-seizure Symptoms in Patients with Developmental and Epileptic Encephalopathies

Neurology

Course Description: This module gives an overview of DEEs and their non-seizure symptoms, and why these symptoms are imp...

The Anti-seizure Medication Landscape and Their Effect on Non-seizure Symptoms

Neurology

Course Description: This module discusses the major anti-seizure medicines used for patients with DEEs and how they impa...

COURSES

ALL

Antibody Drug Conjugates (ADC) - United States

LAUNCH DATE: 11-Sep-2024

EXPIRATION DATE: 11-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

0.50 ANCC Contact Hours

0.50 ACPE

0.50 Pharmacology

Collaborative Care with NSS (Non-Seizure Symptoms) in Mind

LAUNCH DATE: 17-Dec-2024

EXPIRATION DATE: 17-Dec-2025

Neurology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Defining the therapeutic algorithm in patients with HR positive breast cancer - United States

LAUNCH DATE: 11-Sep-2024

EXPIRATION DATE: 11-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

0.50 ANCC Contact Hours

0.50 ACPE

0.50 Pharmacology

Module 1 - Overview of COPD and Optimal Standard-of-Care Therapy

LAUNCH DATE: 02-Dec-2024

EXPIRATION DATE: 02-Dec-2025

Pulmonary Disease

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Module 2 - New Understanding of COPD Pathophysiology and Emerging Biologic Therapies

LAUNCH DATE: 02-Dec-2024

EXPIRATION DATE: 02-Dec-2025

Pulmonary Disease

CREDITS

0.25 AMA PRA Category 1 Credit(s)™